AMR

AMR is bringing better medicine to life. The first step in that journey is the conduct of Phase I trials. AMR - Kansas City operates a highly experienced and large 32 bed Phase I unit under the oversight of Dr. Sue Fanning. Reach out to us at AMRTeam@AMRllc.com to learn more about our Phase I capabilities and experience. #builtonrelationships #phaseIexperts #1994to2024

At AMR, our clients are more than just a trial. They are more than just a number. Because AMR was founded on the value of building relationships that are backed by clear, accurate results. But if you are into numbers, look at these! 800,000+ - database of diverse patients 165,000+ - patients enrolled in AMR trials 8,000+ - clinical site study placements 2,100+ - completed study protocols 550+ - Sponsor & CRO clients 500+ - AMR employees 200+ - board-certified investigators 110% - average enrollment rate 96% - average retention rate 33 - US site locations 15 - states with AMR offices 4 - WVC ViE Awards for Best Site or Network 1 - OUTSTANDING SITE COMPANY #builtonrelationships #30years #amrllc

“Built on Relationships. Backed by Results.” It isn’t just a tagline; it is the cornerstone upon which AMR was created. At AMR, we build and nurture genuine partnerships with Sponsors, CRO’s, our local communities and the patients who live there. With a clear understanding that successful partnerships must be based in service, AMR strives to be an accountable, committed, supportive and trustworthy partner. AMR has delivered superior results for the past 30 years. We have mastered controlling costs and expediting timelines while never compromising on quality. Connect with us at AMRTeam@AMRllc.com. Working together with a shared goal and common purpose can make the impossible possible. #builtonrelationships #AMRllc #1994to2024

AMR - Lexington has been conducting Phase I trials for over a decade. Dr. Mark Adams, with over 40 years of research experience, provides oversight of AMR - Lexington's early phase clinical trials. This Phase I unit is secure and well-equipped for any of AMR’s client needs. With a database of over 40,000 subject volunteers, this site consistently exceeds enrollment. Connect with our Phase I experts at amrteam@amrllc.com for details on partnering with AMR – Lexington. #builtonrelationships #phaseIexperts

Dr. Abid Chaudhry is an accomplished Emergency Medicine physician with 25+ years of experience with an extensive background in providing direct patient care within high volume departments. He is highly skilled in delivering exceptional patient care and support through proper assessment, diagnosis, and treatment. He serves as a primary Principal Investigator at AMR - Miami and has successfully completed over 100 clinical trials. Congratulations to Dr. Chaudhry and the entire team at AMR - Miami! #builtonrelationships #exceedingexpectations #clinicalresearchmatters

AMR Expands Clinical Research Offerings in the Carolinas with Waccamaw Dermatology Partnership AMR, a leading clinical research site company, and Waccamaw Dermatology, renowned for its comprehensive, specialized dermatological care as one of the largest physician-owned and led dermatology practices in the Carolinas, today announced a strategic partnership that expands access to clinical trials in the Carolinas. The partnership between these two award-winning organizations leverages AMR's expertise in clinical trials and enables Waccamaw Dermatology to offer its diverse patient base the opportunity to participate in the latest medical and aesthetic advancements. “Our partnership with Waccamaw Dermatology demonstrates AMR’s commitment to enhancing clinical trial access for diverse patients,” said Kari Delahunty, MBA, Chief Operating Officer of AMR. “Working together with Waccamaw Dermatology, we are poised to make significant advancements in dermatological research and care.” “Skin cancer is on the rise nationwide, and South Carolina, in particular, is underserved, with limited access to dermatologic care. Our partnership with AMR enables us to provide more options to our patients, seamlessly integrate medical research into our practice, and offer Waccamaw Dermatology patients access to the latest advancements in dermatological treatments,” said Dr. Brandon J. Coakley, M.D., Board-Certified Dermatologist, fellowship-trained Mohs Surgeon, and Managing Partner of Waccamaw Dermatology. Patients will have the opportunity to participate in clinical trials initially at Waccamaw Dermatology’s new South Strand location in Myrtle Beach. Additional communities served by Waccamaw Dermatology will launch as the partnership develops. AMR's commitment to expanding its regional footprint and advancing patient care through innovative clinical research is evident with its integration into Waccamaw Dermatology clinics. “Our partnership with Waccamaw Dermatology marks another milestone in AMR’s mission to provide high-quality research while maintaining a focus on patient care,” said Dr. Bill Smith, Chief Executive Officer of AMR. “We are very excited to partner with the superior dermatology group in the Carolinas.” #builtonrelationships #clinicalresearchmatters #partnerships

Dr. William B. Smith has conducted over 2,000 clinical trials over the past 40+ years. Quadruple Board Certified in Nephrology, Cardiology, Internal Medicine and Critical Care Medicine, Dr. Smith has helped change the face of medicine. He is a key opinion leader and protocol development consultant to many pharmaceutical companies who thrives on involvement with drug development and working with scientists and clinicians who are dedicated to improving the lives of patients. Congratulations to Dr. Smith and the entire team at AMR - Knoxville. #builtonrelationships #exceedingexpectations #clinicalresearchmatters

Robert Noveck MD, PhD, FCP, FACEP has been involved in multiple facets of clinical drug development over the past 40+ years including currently acting as Principal Investigator at AMR - New Orleans. His knowledge, dedication and leadership are a powerful combination. Congratulations to AMR's entire New Orleans team! #builtonrelationships #teamwork #researchmatters

Dr. William B. Smith is the CEO of AMR as well as the primary Principal Investigator for AMR – Knoxville’s Phase I Unit. With over 40 years of research experience, Dr. Smith has established himself as an industry leader in early phase clinical trials. The Knoxville CRU is a rare intra-hospital unit that utilizes a Central IRB with no local review board required. The unit is secure and well-equipped for any of AMR’s client needs including continuous telemetry monitoring, state of the art imaging facilities, trauma code team coverage and partnerships with hospital departments needed for complex trials. Knoxville is the largest of AMR’s CPU’s and covers FIH, POC, SAD/MAD, PK, DDI, TQT, special population and patient-based trials. Connect with our Phase I experts at amrteam@amrllc.com for details on partnering with AMR – Knoxville. #builtonrelationships #phaseIexperts

The entire team at AMR wishes our friends and partners a Happy Independence Day! #independenceday #builtonrelationships